Medical Tapes and Bandages Top Companies-Recent Developments, Business Strategy, Deal Strategy, Patent Strategy, Benchmarking and Management Outlook

Date : November 2024

Medical Tapes and Bandages Market Size Analysis and Top Companies

The medical tapes and bandages market size is predicted to hit around USD 11.07 billion by 2033 from USD 8.18 billion in 2024 with a CAGR of 3.42%. The medical tapes and bandages market size is predicted to hit around USD 11.07 billion by 2033 from USD 8.18 billion in 2024 with a CAGR of 3.42%. The top companies operating in the medical tapes and bandages market are Smith & Nephew PLC, Mölnlycke Health Care AB, 3M, McKesson Corporation, Ethicon Inc. (JOHNSON & JOHNSON), B. Braun Melsungen AG, Paul Hartmann AG, Coloplast, Integra Lifesciences, Medtronic Industries, and Others.

Market Report Coverage

Report Coverage Details
Market Size by 2033 USD 11.07 Billion
Market Size in 2023 USD 7.91 Billion
Market Size in 2024 USD 8.18 Billion
Market Growth Rate from 2024 to 2033 CAGR of 3.42%
Largest Market North America
Base Year 2023
Forecast Period 2024 to 2033
Segments Covered Product, Application, End-use, and Regions
Regions Covered North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa


 Medical Tapes and Bandages Key Players

Medical Tapes and Bandages Key Players

  • Smith & Nephew PLC
  • Mölnlycke Health Care AB
  • 3M
  • McKesson Corporation
  • Ethicon Inc. (JOHNSON & JOHNSON)
  • B. Braun Melsungen AG
  • Paul Hartmann AG
  • Coloplast
  • Integra Lifesciences
  • Medtronic Industries

Recent Developments

  • In October 2023, the low-cyclic, higher-adhesion DuPont Liveo MG 7-9960 silicone soft skin adhesive (SSA) is a new product from technology-based materials and solutions supplier DuPont. The novel adhesive is intended for use in advanced wound care dressings, for attaching medical equipment to the skin for prolonged periods of time, and for gently removing them.
  • In July 2023, the Evonik firm JeNaCell introduced the epicite balancing wound dressing to the German market. The dressing, which will be available in June 2023, is especially well-suited and ideal for treating chronic wounds with low to medium exudation, including soft tissue lesions, diabetic foot ulcers, venous leg ulcers, arterial leg ulcers, and pressure ulcers.

We have prepared a service to support you. please feel free to contact us at sales@precedenceresearch.com | +1 804 441 9344